PATENT CLAIM ANALYSIS

Application Number: 15775728
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "020800"]

Abstract:
Disclosed herein are methods and compositions useful for preventing or reducing corneal haze of opacification resulting from Limbal Stem Cell Deficiency (LSCD). The invention comprises a method of preventing or treating corneal opacification, comprising administering to a subject a sufficient amount of a proteasome modulator. The invention also comprises a method of preventing or treating corneal opacification, comprising administering to a subject a sufficient amount of a proteasome modulator. In addition, the invention comprises a method of administering to a subject suffering from corneal opacification with a sufficient amount of proteasome modulator, resulting in reduction of Keratin proteins in the cornea of the subject.

Claim (Index 6):
The method of  claim 1 , wherein the proteasome modulator is oleuropein.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 93.0
- Lexical Diversity: 2.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11119473', '13242209', '12685510', '14768885', '15742867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7708451303582516
- 35 USC 102 Novelty (BERT): 0.509385169095458
- Combined Prediction Score: 0.7446991342319722
- Mean Citation Score: 230.59721600000003
- Max Citation Score: 247.58003
- Similarity Product: 158.67413368795633

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test